JAM
XBI icon

JW Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

JW Asset Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-70,000
Closed -$6.06M – 29
2017
Q3 		$6.06M Buy
70,000
+40,000
+133% +$3.21M 4.44% 5
2017
Q2 		$2.31M Buy
+30,000
New +$2.13M 1.47% 15

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JW Asset Management's XBI Position: Q4 2017 in Review

JW Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2017, closing a stake of 70,000 shares — an estimated $6.06M sold.

JW Asset Management first reported a position in XBI in Q2 2017 and held it in 2 quarters. The position peaked at $6.06M in Q3 2017. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.

  • JW Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • JW Asset Management sold 70,000 State Street SPDR S&P Biotech ETF shares in Q4 2017, an estimated $6.06M.
  • JW Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 2 quarters.
  • JW Asset Management's State Street SPDR S&P Biotech ETF position peaked at $6.06M in Q3 2017.
  • 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.

Based on JW Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.